Earlier today, Stellar Biotechnologies, Inc. (NASDAQ: SBOT) (TSX-V: KLH) announced the presentation of a preclinical poster relating to its ongoing research on Clostridium difficile. The poster, which was presented at the Society for Glycobiology 2015 Annual Meeting in San Francisco, California, reported data from the company’s studies into the potential development of C. difficile cell […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.